Absolute CD4 and CD8 counts and CD4- to CD8 ratios in eight patients with indolent B-cell chronic lymphocytic leukemia

被引:0
作者
Upshaw, JD
Callihan, TR
机构
[1] Memphis Canc Ctr, Memphis, TN USA
[2] Pathol Grp Midsouth, Memphis, TN USA
关键词
B-cell chronic lymphocytic leukemia; CD4 : CD8 ratios; natural resistance;
D O I
10.1097/01.SMJ.0000085747.15986.B6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: There are some patients with B-cell chronic lymphocytic leukemia who exhibit an extraordinary natural resistance to this malignancy, which lasts for many years. In this study, we report the T-cell subset values and ratios in eight such patients. Methods: Impath (New York, NY) evaluated immunophenotyping by performing flow cytometry. Absolute CD4 and CD8 counts and CD4:CD8 ratios were performed at Memphis Pathology Laboratory, Memphis, Tennessee. Results: CD4 and CD8 counts and CD4:CD8 ratios were normal in all eight patients, in contrast to the suppressor cell proliferation and low helper-suppressor ratios that have been previously reported in other patients with B-cell chronic lymphocytic leukemia. Conclusion: These results require further study to determine their significance. Implications for further study are discussed.
引用
收藏
页码:236 / 239
页数:4
相关论文
共 17 条
[1]  
AYANLARBATUMAN O, 1986, BLOOD, V67, P279
[2]   Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma [J].
Bendandi, M ;
Gocke, CD ;
Kobrin, CB ;
Benko, FA ;
Sternas, LA ;
Pennington, R ;
Watson, TM ;
Reynolds, CW ;
Gause, BL ;
Duffey, PL ;
Jaffe, ES ;
Creekmore, SP ;
Longo, DL ;
Kwak, LW .
NATURE MEDICINE, 1999, 5 (10) :1171-1177
[3]  
CHIORAZZI N, 1979, J IMMUNOL, V122, P1087
[4]   EXPANSION OF T-CELLS EXPRESSING LOW CD4 OR CD8 LEVELS IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA - CORRELATION WITH DISEASE STATUS AND NEOPLASTIC PHENOTYPE [J].
DIANZANI, U ;
OMEDE, P ;
MARMONT, F ;
DIFRANCO, D ;
FUSARO, A ;
BRAGARDO, M ;
REDOGLIA, V ;
GIARETTA, F ;
MAIRONE, L ;
BOCCADORO, M ;
RESEGOTTI, L ;
PILERI, A .
BLOOD, 1994, 83 (08) :2198-2205
[5]  
HERRMANN F, 1983, CLIN EXP IMMUNOL, V53, P109
[6]  
HERRMANN F, 1982, CLIN EXP IMMUNOL, V49, P157
[7]  
JANDL JH, 1996, BLOOD TXB HEMATOLOGY, P991
[8]  
KAY NE, 1984, BRIT J HAEMATOL, V57, P105, DOI 10.1111/j.1365-2141.1984.tb08504.x
[10]  
KAY NE, 1989, BLOOD, V73, P1016